Cargando…

The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem

Osteosarcomas are the most frequent primary bone sarcomas, affecting mainly children, adolescents, and young adults, and with a second peak of incidence in elderly individuals. The current therapeutic management, a combined regimen of poly-chemotherapy and surgery, still remains largely insufficient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corre, Isabelle, Verrecchia, Franck, Crenn, Vincent, Redini, Francoise, Trichet, Valérie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226971/ https://www.ncbi.nlm.nih.gov/pubmed/32326444 http://dx.doi.org/10.3390/cells9040976

Ejemplares similares

Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment
por: Verrecchia, Franck, et al.
Publicado: (2018)

SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression
por: Lézot, Frédéric, et al.
Publicado: (2020)

LIM Kinases in Osteosarcoma Development
por: Brion, Régis, et al.
Publicado: (2021)

Molecular Alterations Associated with Osteosarcoma Development
por: Ando, Kosei, et al.
Publicado: (2012)

TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression
por: Lamora, Audrey, et al.
Publicado: (2016)

New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
por: Danieau, Geoffroy, et al.
Publicado: (2019)

Characterization of the Tumor Microenvironment in Jaw Osteosarcomas, towards Prognostic Markers and New Therapeutic Targets
por: Bertin, Hélios, et al.
Publicado: (2023)

Involvement of the TGF-β Signaling Pathway in the Development of YAP-Driven Osteosarcoma Lung Metastasis
por: Morice, Sarah, et al.
Publicado: (2021)

Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence
por: Perrot, Pierre, et al.
Publicado: (2010)

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases
por: Lamora, Audrey, et al.
Publicado: (2015)

Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?
por: Morice, Sarah, et al.
Publicado: (2020)

The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth
por: Morice, Sarah, et al.
Publicado: (2020)

Antagonistic Functions of Connexin 43 during the Development of Primary or Secondary Bone Tumors
por: Talbot, Julie, et al.
Publicado: (2020)

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma
por: Ando, Kosei, et al.
Publicado: (2013)

Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells
por: Ory, B, et al.
Publicado: (2008)

Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL
por: Picarda, Gaëlle, et al.
Publicado: (2013)

Jaw osteosarcoma models in mice: first description
por: Bertin, Hélios, et al.
Publicado: (2019)

Origin and Therapies of Osteosarcoma
por: Moukengue, Brice, et al.
Publicado: (2022)

Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma
por: Le Nail, Louis-Romée, et al.
Publicado: (2018)

ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma Cells
por: Danieau, Geoffroy, et al.
Publicado: (2021)

Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619
por: Lavaud, Mélanie, et al.
Publicado: (2021)

Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment?
por: Gomez-Brouchet, Anne, et al.
Publicado: (2021)

Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues
por: Lallier, Morgane, et al.
Publicado: (2021)

Bone Microenvironment and Osteosarcoma Metastasis
por: Yang, Chaofei, et al.
Publicado: (2020)

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
por: Tian, Hailong, et al.
Publicado: (2023)

TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 Recruitment
por: Brion, Régis, et al.
Publicado: (2022)

Sonic Hedgehog Signature in Pediatric Primary Bone Tumors: Effects of the GLI Antagonist GANT61 on Ewing’s Sarcoma Tumor Growth
por: Mullard, Mathilde, et al.
Publicado: (2020)

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma
por: Redini, Françoise, et al.
Publicado: (2015)

MiR-4270 acts as a tumor suppressor by directly targeting Bcl-xL in human osteosarcoma cells
por: Veys, Clément, et al.
Publicado: (2023)

Epinephrine Infiltration of Adipose Tissue Impacts MCF7 Breast Cancer Cells and Total Lipid Content
por: Avril, Pierre, et al.
Publicado: (2019)

Extracellular vesicles-mediated signaling in the osteosarcoma microenvironment: Roles and potential therapeutic targets
por: Lan, Min, et al.
Publicado: (2018)

Targeting the osteosarcoma cancer stem cell
por: Siclari, Valerie A, et al.
Publicado: (2010)

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma
por: Lamoureux, Francois, et al.
Publicado: (2014)

The Role of Tumor Microenvironment in Regulating the Plasticity of Osteosarcoma Cells
por: Tian, Boren, et al.
Publicado: (2022)

Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis
por: Nirala, Bikesh K., et al.
Publicado: (2023)

Microbiota Ecosystem in Recurrent Cystitis and the Immunological Microenvironment of Urothelium
por: Dominoni, Mattia, et al.
Publicado: (2023)

Tumor Suppressive Role of miR-342-5p and miR-491-5p in Human Osteosarcoma Cells
por: Veys, Clément, et al.
Publicado: (2022)

Bone Sarcomas: From Biology to Targeted Therapies
por: Gaspar, Nathalie, et al.
Publicado: (2012)

Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models
por: Gobin, Bérengère, et al.
Publicado: (2014)

Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma
por: Liu, Yun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aamh6bl54ut7njggl2la7l3cdm